These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1888693)

  • 41. [Ambulatory ergometric and pressurometric results with a daily dose of 240 mg of diltiazem in labile hypertensive patients with threshold ergometry].
    Yasky J; Godoy J; Soutric JL; Arenoso HJ
    Medicina (B Aires); 1991; 51(2):111-20. PubMed ID: 1820496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A dose-response trial of once-daily diltiazem.
    Felicetta JV; Serfer HM; Cutler NR; Comstock TJ; Huber GL; Weir MR; Hafner K; Park GD
    Am Heart J; 1992 Apr; 123(4 Pt 1):1022-6. PubMed ID: 1549966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
    Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
    Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypertension.
    Applegate WB; Cohen JD; Wolfson P; Davis A; Green S
    Am J Cardiol; 1996 Jul; 78(1):51-5. PubMed ID: 8712118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic properties and antihypertensive efficacy of once-daily diltiazem.
    Kelly JG; Devane JG; Geoghegan B
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):957-63. PubMed ID: 1714021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of amlodipine and long-acting diltiazem in the treatment of mild or moderate hypertension.
    Horwitz LD; Weinberger HD; Clegg L
    Am J Hypertens; 1997 Nov; 10(11):1263-9. PubMed ID: 9397246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antihypertensive effect of diltiazem administered once and twice daily.
    Mooser V; Waeber B; Nussberger J; Brunner HR
    J Hum Hypertens; 1988 Dec; 2(4):257-60. PubMed ID: 3236328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Administration-time-dependent effects of diltiazem on the 24-hour blood pressure profile of essential hypertension patients.
    Kohno I; Iwasaki H; Okutani M; Mochizuki Y; Sano S; Satoh Y; Ishihara T; Ishii H; Mukaiyama S; Ijiri H; Komori S; Tamura K
    Chronobiol Int; 1997 Jan; 14(1):71-84. PubMed ID: 9042553
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new extended-release formulation of diltiazem HCl for the treatment of mild-to-moderate hypertension.
    Frishman WH
    J Clin Pharmacol; 1993 Jul; 33(7):612-22. PubMed ID: 8366186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the efficacy and tolerability of an angiotensin converting enzyme inhibitor (lisinopril) versus a calcium channel antagonist (diltiazem SR) in the treatment of moderate to severe hypertension.
    Weir MR; Fagan T; Chrysant S; Flamenbaum W; Kaihlanen PM; Lueg M; Anzalone D
    J Hum Hypertens; 1994 Jul; 8(7):531-7. PubMed ID: 7932518
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Three-period crossover trial with ambulatory blood pressure monitoring for evaluating antihypertensive therapy.
    Meeves S; Hafner K; Park G; Weber M
    Am Heart J; 1995 Oct; 130(4):841-8. PubMed ID: 7572595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension.
    Hosie J; Nasar MA; Belgrave GP; Walters EG
    Acta Cardiol; 1994; 49(3):251-65. PubMed ID: 7941918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of mild hypertension with low once-daily doses of a sustained-release capsule formulation of verapamil.
    Davis PJ; Fagan TC; Topmiller MJ; Levine JH; Ferdinand KC
    J Clin Pharmacol; 1995 Jan; 35(1):52-8. PubMed ID: 7751413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Twenty-four hour efficacy of two dose levels of a once daily sustained-release diltiazem formulation in stable angina: a placebo-controlled trial. The Dildurang Study Group.
    Frances Y; Gagey S; Stalla-Bourdillon A
    Br J Clin Pharmacol; 1995 Mar; 39(3):277-82. PubMed ID: 7619669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension.
    Weir MR; Josselson J; Giard MJ; Warren JB; Posner JN; Lam YW; Zaske DE; Saunders E
    Am J Cardiol; 1987 Dec; 60(17):36I-41I. PubMed ID: 3318375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension.
    Weir MR; Weber MA; Punzi HA; Serfer HM; Rosenblatt S; Cady WJ
    J Hum Hypertens; 1992 Apr; 6(2):133-8. PubMed ID: 1597846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension.
    Frishman WH; Charlap S; Goldberger J; Kimmel B; Stroh J; Dorsa F; Allen L; Strom J
    Am J Cardiol; 1985 Dec; 56(16):41H-46H. PubMed ID: 3934948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diuretics versus calcium-channel blockers in systemic hypertension: a preliminary multicenter experience with hydrochlorothiazide and sustained-release diltiazem.
    Frishman WH; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H; Smith LK; Sowers J; Swartz S; Zawada E
    Am J Cardiol; 1985 Dec; 56(16):92H-96H. PubMed ID: 3907323
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diltiazem and atenolol in essential hypertension: additivity of effects on blood pressure and cardiac conduction with combination therapy.
    Tonkin AL; Wing LM; Russell AE; West MJ; Bune AJ; Morris MJ; Cain MD; Chalmers J
    J Hypertens; 1990 Nov; 8(11):1015-9. PubMed ID: 1963183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.